Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

Peer Review reports

Original Submission
31 Jan 2022	Submitted	Original manuscript
13 Feb 2022	Reviewed	Reviewer Report - Kirsty Loudon
23 Feb 2022	Author responded	Author comments - Seonaidh Cotton
Resubmission - Version 2
23 Feb 2022	Submitted	Manuscript version 2
25 Feb 2022	Author responded	Author comments - Seonaidh Cotton
Resubmission - Version 3
25 Feb 2022	Submitted	Manuscript version 3
Publishing
26 Mar 2022	Editorially accepted
14 Apr 2022	Article published	10.1186/s13063-022-06226-8

Back to article page